Skip to main content

Table 1 Characteristics of cancer patients who die from cancer (cases) compared with controls, by cancer site

From: Drugs affecting the renin-angiotensin system and survival from cancer: a population based study of breast, colorectal and prostate cancer patient cohorts

 

Breast cancer

 

Colorectal cancer

 

Prostate cancer

 
 

Cases

Controls

P

Cases

Controls

P

Cases

Controls

P

 

number (%)

number (%)

 

number (%)

number (%)

 

number (%)

number (%)

 

Year of diagnosis

         

  1998 to 2000

500 (35)

2,466 (35)

N.A.

379 (25)

1,842 (25)

N.A.

396 (33)

1,941 (33)

N.A.

  2001 to 2003

518 (36)

2,570 (36)

 

564 (37)

2,721 (37)

 

461 (39)

2,281 (39)

 

  2003 to 2006

417 (29)

2,070 (29)

 

568 (38)

2,728 (37)

 

327 (28)

1,627 (28)

 

Age at diagnosis (years)

         

  <50

339 (24)

1,667 (23)

N.A.

90 (6)

330 (5)

N.A.

6 (1)

20 (0)

N.A.

  50 to 59

286 (20)

1,430 (20)

 

226 (15)

1,117 (15)

 

71 (6)

351(6)

 

  60 to 69

273 (19)

1,365 (19)

 

401 (27)

2,001 (27)

 

280 (24)

1,400 (24)

 

  70 to 79

318 (22)

1,588 (22)

 

496 (33)

2,472 (34)

 

532 (45)

2,660 (45)

 

  ≥ 80

219 (15)

1,056 (15)

 

298 (20)

1,371 (19)

 

295 (25)

1,418 (24)

 

Male

0 (0)

0 (0)

N.A.

871 (58)

4,231 (58)

N.A.

1,184(100)

5,849 (100)

N.A.

Exposure period (years):

         

Mean (sd)

3.9 (2.3)

3.9 (2.3)

N.A.

2.8 (1.6)

2.9 (1.7)

N.A.

3.8 (2.2)

3.7 (2.2)

N.A.

Range

1.0 to 12.8

1.0 to 12.8

N.A.

1.0 to 10.5

1.0 to 10.5

N.A.

1.0 to 11.9

1.0 to 11.9

 

Stage:1

72 (11)

1,471 (43)

<0.001

61 (6)

1,044 (18)

<0.001

   

  2

402 (61)

1,676 (49)

 

275 (25)

2,496 (44)

    

  3

116 (18)

220 (6)

 

558 (51)

1,981 (35)

    

  4

64 (10)

40 (1)

 

203 (19)

195 (3)

    

  Missing

781

3,699

 

414

1,575

    

Grade:Well

54 (6)

751 (19)

 

81 (7)

562 (9)

<0.001

34 (4)

538 (13)

<0.001

  Moderate

377 (41)

1,900 (49)

 

889 (75)

4,894 (78)

 

217 (28)

2,067 (48)

 

  Poor

492 (53)

1,217 (31)

 

208 (17)

818 (13)

 

516 (67)

1,683 (39)

 

  Missing

512

3,280

 

333

1017

 

417

1561

 

Treatment within six months of diagnosis

         

  Chemotherapy

573 (40)

1,611 (23)

<0.001

651 (43)

1,916 (26)

<0.001

49 (4)

137 (2)

<0.001

  Radiotherapy

700 (49)

3,355 (47)

0.22

302 (20)

1,066 (15)

<0.001

246 (21)

1,276 (22)

0.48

  Surgery

1,087 (76)

5,982 (84)

<0.001

1,214 (80)

65,15 (89)

<0.001

   

  Tamoxifen therapy

709 (49)

4,610 (65)

<0.001

      

  Androgen therapy

      

976 (82)

3,450 (59)

<0.001

  Radical prostatectomya

      

20 (2)

331 (8)

<0.001

Smoking prior to diagnosis

  

0.03

  

0.01

  

<0.001

  Non-smoker

710 (60)

3,827 (64)

 

640 (51)

3,138 (52)

 

453 (47)

2,541 (52)

 

  Ex-smoker

226 (19)

1,072 (18)

 

365 (29)

1,885 (31)

 

331 (34)

1,660 (34)

 

  Current smoker

249 (21)

1,094 (18)

 

249 (20)

983 (16)

 

185 (19)

674 (14)

 

  Missing

250

1,113

 

257

1285

 

215

974

 

BMI prior to diagnosis

  

0.01

  

0.66

  

0.05

  Mean (sd)

26.6 (5.5)

26.2 (5.1)

 

26.5 (4.7)

26.6 (4.8)

 

26.4 (4.0)

26.1 (3.7)

 

  Missing

386

1,633

 

412

1,810

 

302

1,362

 

Alcohol prior to diagnosis

  

0.58

  

0.47

  

0.37

  Alcohol consumer

831 (80)

4,333 (81)

 

950 (87)

4,585 (86)

 

791 (89)

4,047 (90)

 

  Missing

401

1,779

 

420

1,977

 

298

1366

 

Comorbidity (prior to diagnosis or during follow-up time)

         

  Cerebrovascular

89 (6)

383 (5)

0.53

117 (8)

493 (7)

0.19

124 (10)

509 (9)

0.07

  C.P.D.

264 (18)

1,247 (18)

0.60

236 (16)

1295 (18)

0.06

229 (19)

1,110 (19)

0.80

  C.H.D.

60 (4)

249 (4)

0.68

91 (6)

367 (5)

0.13

108 (9)

395 (7)

0.01

  Diabetes

126 (9)

468 (7)

0.02

192 (13)

866 (12)

0.21

141 (12)

619 (11)

0.17

  Myocardial infarction

26 (2)

148 (2)

0.74

104 (7)

454 (6)

0.32

130 (11)

522 (9)

0.03

  Peptic ulcer disease

39 (3)

184 (3)

0.79

111 (7)

477 (7)

0.19

77 (7)

440 (8)

0.18

  P.V.D.

51 (4)

165 (2)

0.003

64 (4)

331 (5)

0.70

113 (10)

396 (7)

0.001

  Renal disease

78 (5)

382 (5)

0.92

107 (7)

478 (7)

0.45

138 (12)

509 (9)

0.001

  Rheumatological

76 (5)

330 (5)

0.35

55 (4)

272 (4)

0.82

37 (3)

287 (5)

0.01

  1. aExcludes cancer registries without available data. C.P.D., chronic pulmonary disease; C.H.D., congestive heart disease; N.A., not applicable; P.V.D., peripheral vascular disease; sd, standard deviation.